Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:3.1.3.1 (alkaline phosphatase)
47,916 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thermostability of the purified alkaline phosphatase derived from human uterine muscle and myoma was established before and after desialization. Both enzymes were inhibited by sucrose, glucose and maltose in proportion to the carbohydrate concentration. L-Homoarginine inhibits the myoma enzyme in 90%, L-leucine, L-histidine and L-tryptophan in about 60%, and L-phenylalanine in less than 15%. The type of inhibition and Ki values were determined. Muscle and myoma enzymes cross-reacted with antisera against human liver and placental isoenzymes. Molecular and kinetic properties of the enzyme were compared with known human isoenzymes of alkaline phosphatase.
...
PMID:Alkaline phosphatase from human uterine myoma. II. Kinetic and immunological properties. 398 59

We characterized the bovine polymorphonuclear neutrophil alkaline phosphatase which was considerably purified with a sp. act. of 206 units/mg of protein. The Km value for p-nitrophenylphosphate at pH 10.0 was 1.69 mM. L-Histidine, imidazole and L-homoarginine but not L-phenylalanine inhibited the enzyme. In heat stability study, the enzyme lost 50% activity at 56 degrees C for 20 min. The enzyme had a half-life of 30 min in 3 M urea at 37 degrees C and pH 7.5. The enzyme was inhibited by beta-mercaptoethanol in a dose-dependent fashion. It is suggested from above results that the neutrophil alkaline phosphatase isozyme could be distinguishable from other tissue isozymes.
...
PMID:Characterization of alkaline phosphatase from bovine polymorphonuclear neutrophils. 409 29

A diagonal-electrophoresis method for the selective purification of serine phosphate peptides was applied to tryptic, chymotryptic and peptic digests of oxidized ovalbumin. This method is based on the release of the phosphate group bound to serine by treatment with alkaline phosphatase on paper. The identified serine phosphate peptides were purified by paper electrophoresis at pH6.5 and 2.0, dephosphorylation with bacterial alkaline phosphatase, and paper electrophoresis at pH2.0 again, in that order. The presence of two groups of serine phosphate peptides was apparent from the amino acid composition. One group contained no lysine, cysteic acid, proline, leucine or isoleucine (sequence 1) and the other had all those amino acids (sequence 2). Further degradation with subtilisin of those peptides and ;dansyl'-Edman sequence analysis established their partial sequences. The proposed sequences are as follows (with ;SerP' representing serine phosphate): sequence 1, -Ala-Gly-Arg-Glu-Val-Val-Gly-SerP-Ala-Glu-Ala-Gly-Asp-Val-Ala-Ala-Ser-(Val,Glx(2),Ser,Phe)-Arg-; sequence 2, -Asp-Lys-Leu-Pro-Gly-Phe-Gly-Asp-SerP-Ile-Glx-Ala-Glx-CySO(3)H-Gly-(Thr,Ser,Val)-(Asp,His,Val)-. The partial sequence of one of the phosphopeptides, Asp-(Glu,Ile,SerP), reported by Flavin (1954) was used to establish the proposed sequence 2.
...
PMID:An application of diagonal electrophoresis to the selective purification of serine phosphate peptides. Serine phosphate peptides from ovalbumin. 488 Nov 41

A 76-year-old man had progressive low back pain, leg weakness, and sensory loss. Radiology showed changes consistent with wide-spread Paget's disease, but no cord compression or involvement of nerve roots was detected by myelography or computerised axial tomography. His symptoms were relieved within 12 days of starting 100 MRC units of subcutaneous salmon calcitonin and recurred when calcitonin was discontinued for 5 days. The improvement continued on calcitonin treatment for 1 year, with falls in serum alkaline phosphatase and urinary hydroxyproline excretion. It is suggested that calcitonin treatment, in reducing the abnormally high metabolic activity of the diseased bone, and hence its vascular perfusion, allows more blood to reach the spinal cord.
...
PMID:Spinal-cord syndrome due to non-compressive Paget's disease of bone: a spinal-artery steal phenomenon reversible with calcitonin. 610 24

Two major forms of human alpha-L-iduronidase have been individually purified over 175,000-fold to apparent homogeneity by sequential anion exchange, lectin affinity, and gel filtration chromatography. The two forms, initially designated as soluble and membrane-associated, were extracted from human lung in approximately equal amounts. Optimal solubilization of the membrane-associated form was facilitated by use of a non-ionic detergent or mannose 6-phosphate and saponin. Following detergent homogenization, the two forms were separated by anion exchange chromatography and then individually purified. The more electronegative form was membrane-associated, had a pI of approximately 5.9, and was selectively taken up (high uptake) by cultured Hurler syndrome fibroblasts; the more electropositive soluble form had a pI of about 6.6 and was incorporated into Hurler fibroblasts at a markedly lower rate (low uptake). After treatment with alkaline phosphatase, the pI values of both enzymes were about 7.8. Using 4-methylumbelliferyl-alpha-L-iduronide as substrate, the low and high uptake forms were each purified in milligram quantities to specific activities of 284,000 and 202,000 units/mg, respectively, with a combined yield greater than 35%. Each purified enzyme form migrated as a single protein band which also stained for enzymatic activity when electrophoresed in 7% native polyacrylamide disc gels at pH 4.3. By gel filtration, the high uptake form had an Mr = 85,000 whereas the Mr for the low uptake form was 68,000. Molecular weight estimates by analytical polyacrylamide gel electrophoresis were 82,000 and 70,000 for the high and low uptake forms, respectively. Rabbit anti-human low uptake alpha-L-iduronidase antibodies cross-reacted with the high uptake form as demonstrated by both immunotitration and Ouchterlony double immunodiffusion. Amino acid analysis revealed that the high uptake (higher molecular weight) form contained more arginine, glycine, alanine, glutamate or glutamine, leucine, isoleucine, histidine, and proline residues per molecule than the low uptake (lower molecular weight) form. Automated Edman degradation determined that the NH2-terminal residues of both forms were blocked. Both sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high performance liquid chromatography demonstrated that each purified form was composed of several components; each post-high performance liquid chromatographic component retained catalytic activity and was immunologically cross-reactive with antibodies against the low uptake form.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Human alpha-L-iduronidase. I. Purification and properties of the high uptake (higher molecular weight) and the low uptake (processed) forms. 642 18

Persistent elevation of the intestinal fraction of the alkaline phosphatase (API) as an isolated finding has to our knowledge not been reported previously. It was found in a boy followed during a period of 5.5 years. The only symptom was transient periodic fatigue observed at home, but not apparent during hospitalization. His blood type was O, RH+, Le (a-, b+) and he was a secretor of H-substance, which may be associated with rising API activity after fat-loading. In this case API was unchanged after fat-loading. Neither intestinal nor liver diseases were found, and no other cause for the elevated phosphatase activity could be demonstrated.
...
PMID:Persistently increased intestinal fraction of alkaline phosphatase. 646 33

beta,beta-[gamma-13C]Dideuteriohistidine has been biosynthetically incorporated into alkaline phosphatase from Escherichia coli and utilized as a nonperturbing 13C nuclear magnetic resonance (NMR) probe of the environments of the histidine residues in this zinc metalloenzyme. The 13C NMR spectrum of the labeled enzyme exhibits 9 separate resonances arising from the 10 histidine residues located in each of the symmetrically disposed subunits of the dimer. The excellent resolution and large chemical shift range (14 ppm) displayed by these signals are direct consequences of the sensitivity of the histidine gamma-carbon chemical shift to the ionization state and tautomeric form of the imidazole side chains and the coordination of several of these to metal ion. The environments of the individual histidine residues were inferred by investigating the chemical shift responses of their 13C resonances to enzyme metal composition, pH, and inhibitor binding. Additional information concerning their motional freedom was obtained from spin relaxation measurements which were analyzed in terms of the contributions expected from intramolecular 13C-1H and 13C-14N dipolar relaxation and chemical shift anisotropy. The combined results indicate that 4 of the 10 histidines, the only ones that titrate with pH, are surface residues located relatively remote from the active site. Of the six nontitrating residues, one appears to be buried in a solvent-inaccessible region of the protein. Three others are almost certainly involved in metal ion ligation to active-site metal ion(s), two via their N pi nitrogen atoms and the other via N pi. The spectral characteristics of the remaining two histidine residues strongly suggest they are also located at or near the active site. One or both may also participate in metal ion coordination, although the current evidence for this is inconclusive.
...
PMID:Characterization of the histidine residues in alkaline phosphatase by carbon-13 nuclear magnetic resonance. 699 13

Carbon-13 nuclear magnetic resonance (13C NMR) of Escherichia coli alkaline phosphatase labeled biosynthetically with beta,beta-[gamma-13C]dideuteriohistidine has been used to determine the number and identity of the histidine residues that participate in metal ion coordination at the three classes of binding sites in this dimeric Zn2+ metalloenzyme. Detailed 13C NMR titrations of the apoenzyme with 113Cd2+ and Mg2+, in conjunction with parallel 13 Cd NMR measurements [Otvos, J.D., & Armitage, I.M. (1980) Biochemistry (third of three papers in this issue)], permitted the assignment of four histidine residues as ligands to the "catalytic", or A site, metal ions, two coordinated via their N pi imidazole nitrogens and two via N pi. In addition, a fifth histidyl ligand, coordinated through N pi, was shown to be located at the "structural", or B, sites on the dimer. The "regulatory", or C, sites do not contain histidyl metal ligands. Unambiguous identification of the three histidines coordinated to metal ion via N pi was provided by the observation of resolved 113Cd-13C spin-spin coupling (3J = 12-19 Hz) in their gamma-carbon resonances. Once assigned, the 13C resonances of the five histidyl metal ligands were used to monitor the relative affinities of the A, B, and C sites for Cd2+ and Zn2+. At pH 6.3, Cd2+ was found to bind to the A sites at least 10 times tighter than to the B or C sites, which have roughly equal affinities. In marked contrast, Zn2+ was found to have similar affinities for the A and B sites at both pH 6.3 and 8.0. The affinity of the C sites for Zn2+ and Mg2+ was shown to be at least an order of magnitude lower. The binding constants of all three sites for Cd2+ and Zn2+ are greater than 10(5) M-1. Evidence is also presented that suggests that the A, B, and C sites may be located in close proximity to one another in the monomers.
...
PMID:Characterization of the properties of the multiple metal binding sites in alkaline phosphatase by carbon-13 nuclear magnetic resonance. 699 14

Chemical modification of Escherichia coli alkaline phosphatase using the group-specific reagent, ethoxyformic anhydride, has demonstrated that 3 histidyl residues/subunit are modified with a concomitant loss of enzyme activity. Reaction with [14C]ethoxyformic anhydride indicates that only three ethoxyformyl groups are incorporated per subunit, confirming that no other amino acid residues are modified under these conditions. Zinc ions protect alkaline phosphatase from inactivation as well as from histidine modification, thus implicating all 3 histidyl residues in Zn2+ binding. The ethoxyformylation reaction was also used to characterize Zn2+ binding sites in immobilized dimeric and monomeric alkaline phosphatase derivatives. The immobilized dimeric alkaline phosphatase was inactivated with ethoxyformic anhydride at a rate similar to that of the soluble enzyme, demonstrating that immobilization did not significantly alter the chemical environment of the Zn2+ binding site. The catalytically inactive, immobilized monomer of alkaline phosphatase was modified more rapidly with ethoxyformic anhydride, demonstrated by the loss of its ability to form functionally active enzyme upon titration with nascent soluble subunits. Moreover, Zn2+ protects the immobilized subunit alkaline phosphatase against this modification, indicating that the isolated subunits of alkaline phosphatase bind Zn2+. These results are consistent with a model for renaturation of the dimeric enzyme in which individual subunits refold and bind Zn2+ before which individual subunits refold and bind Zn2+ before establishing subunit interactions to regain catalytic activity.
...
PMID:Evidence for histidyl residues at the Zn2+ binding sites of monomeric and dimeric forms of alkaline phosphatase. 701 46

The activity of plasma membrane alkaline phosphatase and both mitochondrial and peroxisomal histidine-glyoxylate aminotransferase was significantly increased in the livers of male rats following treatment with the hypolipidemic drug clofibrate. Cycloheximide or puromycin administration to rats inhibited the effects of clofibrate.
...
PMID:Inducing effect of clofibrate on alkaline phosphatase and histidine-glyoxylate aminotransferase in rat liver. 708 2


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---